# Functional Determinants of Metastatic Dormancy

> **NIH NIH R01** · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · 2021 · $234,705

## Abstract

SUMMARY. The majority of cancer patients die of metastases originating from disseminated cancer cells
(DCCs), years and decades after treatment. This has been linked to the ability of DCCs to survive in a dormant
state and evade therapies. Our long-term goal is to understand dormancy of DCCs as a systemic disease
mechanism to target them and prevent relapse. Our overarching hypothesis is that complementary mechanism
between gene programs in primary lesions and target organs niche signals, converge to instruct DCCs in
target organs to enter dormancy via quiescence, pluripotency and survival programs. We further hypothesize
that such signals can be manipulated to suppress metastasis. Using epithelial cancer models we have
discovered that early dissemination spawns mesenchymal-like (M-Like) dormant breast cancer (BC) DCCs.
We also discovered that hypoxia in advanced primary tumors can prime DCC precursors to activate
quiescence programs and enter dormancy in target organs. Importantly, M-like early DCC precursors also
display a strong hypoxia response. Both early and late DCCs were found to respond to retinoic acid, WNT5A,
BMP7 and TGF2 signals derived from stromal target organ niches. These activate transcriptional programs
integrated by ZFP281 (a novel early DCC dormancy regulator) and NR2F1 to induce dormancy. Our new aims
build on these findings and explore three significant new discoveries: 1) Hypoxia signals in early and late
primary lesions turn on quiescence programs that epigenetically imprint DCC precursors to enter dormancy
when they arrive to target organs, 2) early or late DCCs that arrive to the bone marrow (BM) enter dormancy in
response to TGF2 and BMP7 produced by Nestin+/NG2+ mesenchymal stem cells (N+MSCs), which control
hematopoietic stem cells (HSCs) dormancy; loss of N+MSCs or TGF2 expression in these MSCs led to bone
metastasis and 3), in lungs, early and late DCCs reside in pro-dormancy niches orchestrated by alveolar
macrophages (AMs), which when depleted awaken dormant DCCs. We propose to study how signals from
primary lesion hypoxia along with BM and lung homeostatic niches are integrated to keep DCCs dormant. The
specific aims are: AIM 1. Determine how hypoxia primes DCCs for dormancy. AIM 2. Determine how
NG2+/Nestin+ MSCs orchestrate dormancy niches and how aging affects these mechanisms. AIM 3.
Determine how tissue resident lung alveolar macrophages (AMs) dictate DCC fate and how aging impacts the
function of these niches. Our proposal will integrate how primary lesions (early or late) may pre-program DCCs
for dormancy in defined target organ niches which further reinforce dormancy via specific cues, which may be
affected by aging. This approach will aid the design of rational methods to predict dormancy onset, monitor
residual cancer and develop therapies to induce and maintain dormancy or eradicate minimal residual cancer.

## Key facts

- **NIH application ID:** 10299241
- **Project number:** 2R01CA109182-18
- **Recipient organization:** ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- **Principal Investigator:** Julio A. Aguirre-Ghiso
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $234,705
- **Award type:** 2
- **Project period:** 2005-04-01 → 2021-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10299241

## Citation

> US National Institutes of Health, RePORTER application 10299241, Functional Determinants of Metastatic Dormancy (2R01CA109182-18). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10299241. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*